Waters Corporation (WAT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 04 2026 to Jun 28 2025 - CSIMarket
CSIMarket
 


Waters Corporation  (NYSE: WAT)


Waters's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Waters's ROI in the second quarter of 2026?
Waters Corporation achieved a return on average invested assets (ROI) of 1.21 % in its second quarter of 2026, which is below Waters's average return on investment, which stands at 17.33%.

ROI decreased relative to the period ending Apr 04 2026, due to the decline in net income.

Within the Healthcare sector 99 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jul 04 2026 quarter, so far to 1438, from total ROI ranking in the first quarter of 2026 at 1443.

Definition and Formula of Return on Investment



Return On Investment (Jul 04 2026)
II. Quarter
(Apr 04 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Investment Change TTM 237.46 % 83.65 % -18.94 % -28.23 % -22.34 %
Y / Y Net Income Change TTM -74.8 % -31.39 % 20.47 % 112.53 % 361.82 %
Investment (TTM) in Millions 25,287 22,258 3,785 3,561 3,649
Return On Investment (TTM) 1.21 % 5.4 % 17.64 % 17.83 % 16.21 %
WAT's Overall Ranking # 1438 # 1443 # 273 # 123 # 247
Seq. Investment Change TTM 65.07 % 128.18 % 0.49 % -10.84 % -10.17 %
Seq. Net Income Change TTM -63.02 % -30.09 % -0.62 % -1.91 % 0.67 %
Net Income (TTM) in Millions 166 449 643 647 659




Return On Investment WAT's Ranking
Within: No.
Industry # 5
Sector # 100
Overall # 1438

Return On Investment Statistics
High Average Low
27.29 %
17.33 %
0.46 %
(Sep. 30, 2006)   (Dec 31 2017)







Financial Statements
Waters's II. Quarter Investments $ 25,287 Millions WAT's Balance sheet
Waters's II. Quarter Income $ -136 Millions Quarterly WAT's Income Statement
WAT's Income by Division See WAT's Income by Division


WAT Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 3,785 3,714 5,944 3,722 3,545
Y / Y Investment Growth 1.91 % -37.52 % 59.68 % 4.99 % 19.82 %
Net Income in Millions 643 638 642 708 693
Y / Y Net Income Growth 0.75 % -0.69 % -9.26 % 2.15 % 32.84 %
Annual Return On Investment 16.98 % 17.18 % 10.81 % 19.01 % 19.54 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 16.98 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
WAT's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for WAT's Competitors
Subscribers only: Roi for Waters's Suppliers
Subscribers only: Return On Investment for WAT's Customers

Other Ratios
WAT's Roa WAT's Inventory Turnover Ratio WAT's Growth Rates WAT's Dividend Statistics
WAT's Profitability Ratios WAT's Asset Turnover Ratio WAT's Dividend Growth
WAT's Roe WAT's Valuation Ratios WAT's Financial Strength Ratios WAT's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 04 2026, within Healthcare Sector ROI
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %
Cormedix Inc   1.31 %
Pacira Biosciences inc   1.29 %
Waters Corporation  1.20 %
Surgery Partners Inc   1.02 %
Warby Parker Inc   0.98 %
Staar Surgical Co  0.98 %
Biomarin Pharmaceutical Inc  0.91 %
Icu Medical Inc  0.87 %
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %


Date modified: 2026-09-26T07:09:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.